In This Article:
In the current global market landscape, marked by fluctuating indices and policy uncertainties, investors are keenly observing sectors that might benefit from potential regulatory changes under the new administration. Amidst these developments, companies with strong growth trajectories and significant insider ownership often attract attention for their potential resilience and alignment of interests between management and shareholders.
Top 10 Growth Companies With High Insider Ownership
| Name | Insider Ownership | Earnings Growth |
| People & Technology (KOSDAQ:A137400) | 16.4% | 37.3% |
| Archean Chemical Industries (NSEI:ACI) | 22.9% | 43% |
| Kirloskar Pneumatic (BSE:505283) | 30.3% | 26.3% |
| On Holding (NYSE:ONON) | 31% | 29.7% |
| Seojin SystemLtd (KOSDAQ:A178320) | 31.1% | 52.4% |
| Medley (TSE:4480) | 34% | 31.7% |
| Credo Technology Group Holding (NasdaqGS:CRDO) | 13.8% | 95% |
| Plenti Group (ASX:PLT) | 12.8% | 107.6% |
| Brightstar Resources (ASX:BTR) | 16.2% | 84.6% |
| UTI (KOSDAQ:A179900) | 33.1% | 134.6% |
Below we spotlight a couple of our favorites from our exclusive screener.
Admicom Oyj
Simply Wall St Growth Rating: ★★★★★☆
Overview: Admicom Oyj provides ERP cloud-based solutions in Finland and has a market capitalization of €243.84 million.
Operations: The company's revenue is primarily derived from its Software & Programming segment, which generates €34.78 million.
Insider Ownership: 21.9%
Earnings Growth Forecast: 20.5% p.a.
Admicom Oyj is positioned for significant growth, with earnings projected to increase by 20.53% annually, outpacing the Finnish market's 14.4%. Although revenue growth is slower at 8.7%, it still exceeds the market average of 2.6%. The company's Return on Equity is expected to reach a high of 24.1% in three years, and its stock trades at a considerable discount to estimated fair value, despite large one-off items affecting results recently.
-
Click here and access our complete growth analysis report to understand the dynamics of Admicom Oyj.
-
Our expertly prepared valuation report Admicom Oyj implies its share price may be too high.
Runben Biotechnology
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Runben Biotechnology Co., Ltd. focuses on the research, production, and sale of mosquito repellent products, baby care products, and essential oil products with a market cap of CN¥9.79 billion.
Operations: The company's revenue primarily comes from its personal products segment, totaling CN¥1.25 billion.
Insider Ownership: 33.1%
Earnings Growth Forecast: 22.7% p.a.
Runben Biotechnology is poised for robust growth, with revenue forecasted to expand by 24.8% annually, surpassing the Chinese market's average of 13.9%. Earnings are expected to grow significantly at 22.68% per year, although slightly below the market's 26.1%. Recent earnings show a strong performance with sales reaching CNY 1.04 billion and net income rising to CNY 260.88 million over nine months. The stock trades below the market P/E ratio at 32x, indicating potential value.